Local and systemic cellular immunity in early renal artery atherosclerosis

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 2, 2012, Pages 224-230

  Kotliar, Carol ^a   Juncos, Luis ^b   Inserra, Felipe ^a   de Cavanagh, Elena M V ^a   Chuluyan, Eduardo ^c,d   Aquino, Jorge B ^a,d   Hita, Alejandro ^a   Navari, Carlos ^a   Sánchez, Ramiro ^d  

^a UNIVERSIDAD AUSTRAL   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d FAVALORO UNIVERSITY   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN S 100;

ADULT; ARTICLE; AUTOPSY; BLOOD; CAROTID ARTERY; CD4 CD8 RATIO; CELL COUNT; CELL SUBPOPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CORONARY ARTERY; DENDRITIC CELL; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; MEDICAL HISTORY; NEPHROSCLEROSIS; PILOT STUDY; PROSPECTIVE STUDY; RENAL ARTERY; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD86; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; AUTOPSY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULINS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL ARTERY; S100 PROTEINS;

EID: 84857187997     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06270611     Document Type: Article

References (40)

1. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999
2. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002
3. Hansson GK, Libby P, Schönbeck U, Yan ZQ: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91: 281-291, 2002
4. Hansson GK: Immune mechanisms in atherosclerosis. Arte-rioscler Thromb Vasc Biol 21: 1876-1890, 2001
5. Yamashita H, Shimada K, Seki E, Mokuno H, Daida H: Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol 91: 133-136, 2003
6. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J: Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69: 377-381, 1993
7. Wick G, Perschinka H, Millonig G: Atherosclerosis as an autoimmune disease:Anupdate. Trends Immunol 22: 665-669, 2001
8. Zhou X, Stemme S, Hansson GK: Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol 149: 359-366, 1996
9. Weis M, Schlichting CL, Engleman EG, Cooke JP: Endothelial determinants of dendritic cell adhesion and migration: New implications for vascular diseases. Arterioscler Thromb Vasc Biol 22: 1817-1823, 2002
10. Millonig G, Niederegger H, Rabl W, Hochleitner BW, Hoefer D, Romani N, Wick G: Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol 21: 503-508, 2001
11. Sharma R, Li DZ: Role of dendritic cells in atherosclerosis. Asian Cardiovasc Thorac Ann 14: 166-169, 2006
12. Nakajima T, Goek O, Zhang X, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM: De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res 93: 106-113, 2003
13. Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, Weyand CM: Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 100: 2135-2139, 1999
14. Yilmaz A, Lipfert B, Cicha I, Schubert K, Klein M, Raithel D, Daniel WG, Garlichs CD: Accumulation of immune cells and high expression of chemokines/chemokine receptors in the upstream shoulder of atherosclerotic carotid plaques. Exp Mol Pathol 82: 245-255, 2007
15. Bloch MJ, Basile J: Diagnosis and management of renovascular disease and renovascular hypertension. J Clin Hypertens (Greenwich) 9: 381-389, 2007
16. Baumgartner I, Lerman LO: Renovascular hypertension: screening and modern management. Eur Heart J 32: 1590-1598, 2011
17. Textor SC, Wilcox CS: Renal artery stenosis: Acommon,treatable cause of renal failure? Anun Rev Med 52: 421-442, 2001
18. Blaufox MD, Middleton ML, Bongiovanni J, Davis BR: Cost efficacy of the diagnosis and therapy of renovascular hypertension. J Nucl Med 37: 171-177, 1996
19. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM: Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: A meta-analysis. Ann Intern Med 135: 401-411, 2001
20. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK: Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6: 131-138, 1986
21. Hansson GK, Holm J, Jonasson L: Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 135: 169-175, 1989
22. Rundback JH, Sacks D, Kent KC, Copper C, Jones D, Murphy T, Rosenfield K, White C, Bettman M, Cortell S, Puschett S, Clair D, Cole P; AHA Councils on Cardiovascular Radiology, High Blood Pressure Research, Kidney in Cardiovascular Disease, Cardio-Thoracic and Vascular Surgery, and Clinical Cardiology and the Society of Interventional Radiology FDA Device Forum Com-mitee: Guidelines for the reporting of renal artery re-vascularization in clinical trials. American Heart Association. Circulation 106:1572-1585, 2002
23. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20: 1262-1275, 2000
24. Shi C, Lee W-S, He Q, Zhang D, Fletcher DL, Newell JB, Haber E: Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci USA 93: 4051-4056, 1996
25. +) T cells aggravates atherosclerosis in immunodeficient apolipo-protein E knockout mice. Circulation 102: 2919-2922, 2000
26. George J, Afek A, Gilburd B, Shoenfeld Y, Harats D: Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J Am Coll Cardiol 38: 900-905, 2001
27. Sakaguchi S: Naturally arising CD4+ regulatory t cells for im-munologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562, 2004
28. O'Garra A, Vieira P: Regulatory T cells and mechanisms of immune system control. Nat Med 10: 801-805, 2004
29. Yilmaz A, Lochno M, Traeg F, Cicha I, Reiss C, Stumpf C, Raaz D, Anger T, Amann K, Probst T, Ludwig J, Daniel WG, Garlichs CD: Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 176: 101-110, 2004
30. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM: Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101: 2883-2888, 2000
31. Zhang X, Niessner A, Nakajima T, MA-Krupa W, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res 98: 524-531, 2006
32. Moos MP, John N, Gräbner R, Nossmann S, Günther B, Vollandt R, Funk CD, Kaiser B, Habenicht AJ: The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25: 2386-2391, 2005
33. Xu QB, Oberhuber G, Gruschwitz M, Wick G: Immunology of atherosclerosis: Cellular composition and major histocom-patibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol 56: 344-359, 1990.
34. Jongstra-Bilen J, Haidari M, Zhu SN, Chen M, Guha D, Cybulsky MI: Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J Exp Med 203: 2073-2083, 2006
35. Liu P, Yu YR, Spencer JA, Johnson AE, Vallanat CT, Fong AM, Patterson C, Patel DD: CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler Thromb Vasc Biol 28: 243-250, 2008
36. Ferencĺk M, Stvrtinová V, Hulĺn I: Defects in regulation of local immune responses resulting in atherosclerosis. Clin Dev Immunol 12: 225-234, 2005
37. Wick G, Romen M, Amberger A, Metzler B, Mayr M, Falkensammer G, Xu Q: Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J 11: 1199-1207, 1997
38. Stüve O, Marra CM, Bar-Or A, Niino M, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Jerome KR, Cook L, Grand'Maison F, Hemmer B, Monson NL, Racke MK: Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol 63: 1383- 1387, 2006
39. Artemiadis AK, Anagnostouli MC: Apoptosis of oligodendrocytes and post-translational modifications of myelin basic protein in multiple sclerosis: possible role for the early stages of multiple sclerosis. Eur Neurol 63: 65-72, 2010
40. Croxford JL, Olson JK, Miller SD: Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Autoimmun Rev 1: 251-260, 2002